1449 studies found for:    "Hepatitis C"
Show Display Options
Rank Status Study
21 Completed Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Intervention: Biological: PegIntron (peginterferon alfa-2b)
22 Completed A Study of ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 HCV Infected Subjects
Conditions: Chronic Hepatitis C;   Hepatitis C (HCV);   Hepatitis C Genotype 1
Interventions: Drug: ABT-450/r;   Drug: ABT-333;   Drug: ABT-267;   Drug: Ribavirin (RBV)
23 Completed
Has Results
Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
Conditions: Chronic Hepatitis C;   Hepatitis C;   HIV Infections
Interventions: Biological: PEG-IFN alfa-2b;   Drug: RBV
24 Completed
Has Results
Pharmacoeconomic Study Assessing the Cost of Chronic Hepatitis C Treatment With Peginterferon Alfa-2b (PegIntron) and Ribavirin (Rebetol) in the Czech Republic (Study P04588)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Biological: peginterferon alfa-2b;   Drug: ribavirin
25 Completed Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Drug: peginterferon alfa-2b;   Drug: ribavirin
26 Terminated Prediction of Hepatitis C Recurrence in Liver Transplant Recipients
Conditions: Complication of Transplanted Liver;   Hepatitis C, Chronic
27 Active, not recruiting A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C
Conditions: Chronic Hepatitis C;   CHC;   HCV;   Hepatitis C
Interventions: Drug: VX-135;   Drug: Daclatasvir
28 Completed Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)
Conditions: Hepatitis C, Chronic;   Hepatitis C
Interventions: Drug: PegIntron (peginterferon alfa-2b; SCH 54031);   Drug: Rebetol (ribavirin; SCH 18908)
29 Completed Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects
Conditions: Chronic Hepatitis C;   Hepatitis C Virus (HCV)
Interventions: Drug: ABT-267;   Drug: Peginterferon alpha-2a (pegIFN);   Drug: Ribavirin (RBV);   Drug: Placebo
30 Completed
Has Results
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
Condition: Hepatitis C
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin
31 Active, not recruiting A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in People With Chronic Hepatitis C
Condition: Hepatitis C
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin (RBV)
32 Active, not recruiting A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection
Condition: Hepatitis C Virus
Interventions: Drug: ABT-450/r;   Drug: ABT-267;   Drug: Ribavirin
33 Completed Gamma Interferon Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Gamma Interferon 1b
34 Completed
Has Results
A Study of TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: TMC435;   Drug: Peginterferon alfa-2b (pegIFN alfa-2b);   Drug: Ribavirin (RBV)
35 Enrolling by invitation Hepatitis C Treatment in Underserved Populations
Conditions: Chronic Hepatitis C;   Illicit Drug Use
Intervention: Other: Collaborative, multidisciplinary, integrated care
36 Enrolling by invitation A Follow up Study Designed to Obtain Long Term Data on Subjects Who Either Achieved a Sustained Virologic Response or or Did Not Achieve a Sustained Virologic Response in an Abbott Sponsored Hepatitis C Study
Condition: Hepatitis C
Interventions: Drug: ABT-450/ritonavir;   Drug: ABT-333;   Drug: ABT-267
37 Completed Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland
Conditions: Hepatitis C, Chronic;   Substance Abuse Treatment Centers;   Opioid-Related Disorders
38 Active, not recruiting Miravirsen Study in Null Responder to Pegylated Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Miravirsen sodium
39 Completed
Has Results
PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated Interferon/ribavirin
40 Completed
Has Results
A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients
Condition: Hepatitis C, Chronic
Interventions: Drug: Placebo;   Drug: TMC435;   Drug: Peginterferon alfa-2a (pegIFN alfa-2a);   Drug: Ribavirin (RBV)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years